A detailed history of Index Fund Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Index Fund Advisors, Inc. holds 1,434 shares of ABBV stock, worth $251,781. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,434
Holding current value
$251,781
% of portfolio
0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$163.84 - $199.33 $234,946 - $285,839
1,434 New
1,434 $283,000
Q3 2022

Oct 27, 2022

BUY
$134.21 - $153.93 $53,684 - $61,572
400 Added 8.61%
5,045 $677,000
Q2 2022

Jul 27, 2022

BUY
$137.62 - $174.96 $48,167 - $61,236
350 Added 8.15%
4,645 $711,000
Q1 2022

Apr 25, 2022

SELL
$131.98 - $163.75 $87,106 - $108,075
-660 Reduced 13.32%
4,295 $696,000
Q4 2021

Jan 26, 2022

BUY
$107.43 - $135.93 $532,315 - $673,533
4,955 New
4,955 $671,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Index Fund Advisors, Inc. Portfolio

Follow Index Fund Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Index Fund Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Index Fund Advisors, Inc. with notifications on news.